Cellular biomedicine group, inc. (CBMG)
CashFlow / Yearly
Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss

-49,984

-38,945

-25,490

-28,208

-19,447

-15,474

-13,797

-7,031

-516

-174

Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization

-

-

-

-

-

-

-

102

-

-

Loss on disposal of assets

-148

-1

0

0

-

-

-

0

-

-

Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization

5,638

5,049

2,985

2,635

2,094

1,190

841

-

-

-

Loss on disposal of assets

-39

-4

-0

-2

-1

-257

0

-

-

-

Stock based compensation expense

4,063

4,826

5,345

5,452

7,592

2,528

4,381

-

-

-

Other than temporary impairment on investments

0

29

0

4,611

123

1,427

0

-

-

-

Stock based compensation expense

-

-

-

-

-

-

83

1,446

417

584

Impairment on intangible assets

0

2,884

0

0

-

-

-

-

-

-

Interest income from six-month deposits with the banks

0

175

0

0

-

-

-

-

-

-

Interest income from pledged bank deposits

-500

0

0

-

-

-

-

-

-

-

Interest expense

481

0

0

-

-

-

-

-

-

-

Realized losses from sale of investments

-

-

-

-

-5

-5

-138

-

-

-

Third party services received in exchange for disposition of investment stock

-

-

-

-

-

-

-

0

-

-

Loss recognized in excess of cash received on disposition of investment stock

-

-

-

-

-

-

-

0

-

-

Value of stock received for services

-

-

-

-

-

1,610

3,500

0

-250

-1,614

Impairment of goodwill

-

-

-

-

-

3,299

4,258

0

-

-

Reversal of inventory provision

-

-

-

-115

123

0

0

-

-

-

Allowance for doubtful account

0

84

0

10

0

0

-

-

-

-

Decrease in fair value of accrued expenses for the acquisition of intangible assets

-

-

-

-

-345

0

0

-

-

-

Deferred tax

-

-

-

-

-

-

-76

-

-

-

Changes in operating assets and liabilities:
Accounts receivable

-0

-107

160

-537

497

-20

-10

-45

-

-

Other receivables

150

-66

467

156

143

25

-50

-

-

-

Other receivables

-

-

-

-

-

-

-

0

-

-

Inventory

-

-

-

-514

142

78

81

-6

-

-

Prepaid expenses

-831

-68

812

669

-181

494

38

-

-

-

Prepaid expenses

-

-

-

-

-

-

-

-404

-

-

Other current assets

-

-

-

-

-110

-24

84

0

-

-

Investments

-

-

-

-

-

-7

0

-

-

-

Long-term prepaid expenses and other assets

1,324

538

1,005

643

384

504

-134

0

-

-

Loss on the extinguishment of debt

-

-

-

-

-

-

-

-

-52

476

Value of investment stock exchanged for cash and services

-

-

-

-

-

-

-

-

435

0

Advances receivable from related party

-

-

-

-

-

-

-

-

0

23

Accounts payable

1,170

133

-0

-28

-166

165

40

-2,311

-108

178

Accrued expenses

48

816

-118

356

396

409

-739

0

434

250

Deferred income

-

-

-

-

-

-

-

0

41

131

Advance payable to related party

-

-

-

-

-30

0

0

-

-

-

Other current liabilities

-43

390

1,339

-640

113

-694

186

0

-53

53

Taxes payable

-

-

-

150

-150

0

0

-121

-

-

Taxes payable

-2

0

0

28

-814

-176

-10

-

-

-

Other non-current liabilities

80

83

-208

296

-371

0

-251

-

-

-

Net cash used in operating activities

-39,649

-25,112

-18,593

-15,867

-11,751

-9,720

-8,455

-7,458

347

-90

CASH FLOWS FROM INVESTING ACTIVITIES:
Withdrawing six-month deposits with the banks

0

10,175

0

0

-

-

-

-

-

-

Putting six-month deposits with the banks

0

10,000

0

0

-

-

-

-

-

-

Acquisition of business, net of cash acquired

-

-

-

-

1,568

1,485

0

-

-

-

Proceed from sale of investments, net of transaction costs

-

-

-

-

1

0

0

-

-

-

Purchases of intangibles

869

196

23

56

4,260

8

5

1,082

-

-

Purchases of property, plant and equipment

10,674

6,589

10,169

2,676

1,874

311

147

-

-

-

Purchases of assets

-

-

-

-

-

-

-

644

-

-

Net cash used in investing activities

-11,395

-6,609

-10,192

-2,733

-7,702

-1,806

-153

-1,726

-

-

CASH FLOWS FROM FINANCING ACTIVITIES:
Net proceeds from the issuance of common stock

17,166

70,351

14,496

42,399

18,964

19,121

11,561

8,916

-

-

Proceeds from exercise of stock options

283

2,738

308

885

682

19

0

-

-

-

Proceeds from short-term debt

14,546

0

0

-

-

-

-

-

-

-

Interest paid

470

0

0

-

-

-

-

-

6

0

Treasury stock purchase, amount

-1,039

-9,975

-3,977

0

0

-

-

-

-

-

Repayment of line of credit

-

-

-

-

-

-

-

-

18

45

Advance from affiliates

-

-

-

-

-

-

36

0

223

22

Repayment of advance from affiliate

-

-

-

-

-

-31

-1

0

-

-

Net cash provided by financing activities

30,486

63,114

10,826

43,285

19,647

19,109

11,596

8,916

204

-22

EFFECT OF EXCHANGE RATE CHANGES ON CASH

190

-147

275

-316

-79

12

41

0

-

-

INCREASE (DECREASE) IN CASH, CASH EQUIVALENTS AND RESTRICTED CASH

-20,369

31,244

-17,684

24,367

114

7,595

3,030

-269

552

-112

SUPPLEMENTAL CASH FLOW INFORMATION
Cash paid for income taxes

3

4

2

6

108

460

0

-

0

9

Acquisition of intangible assets through issuance of the Company's stock

-

-

-

-

1,481

1,442

0

-

-

-

Acquisition of business through issuance of the Company's stock

-

-

-

-

-

14,496

0

-

-

-

Issuance of company stock for accrued liabilities and advances

-

-

-

-

-

-

149

0

-

-

Issuance of company stock for accrued liabilities

-

-

-

-

-

-

-

-

7

0

Debt extinguished with issuance of company stock

-

-

-

-

-

-

-

-

152

75